Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors
Tango Therapeutics, Inc.
Tango Therapeutics, Inc.
Instituto do Cancer do Estado de São Paulo
Vastra Gotaland Region
Travera Inc
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Genmab
KaliVir Immunotherapeutics
Fudan University
National Institutes of Health Clinical Center (CC)
Tango Therapeutics, Inc.
Beijing Biotech
IDEAYA Biosciences
Vivace Therapeutics, Inc
AstraZeneca
iOnctura
Sotio Biotech Inc.
Massachusetts General Hospital
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Ohio State University
University Health Network, Toronto
Endeavor Biomedicines, Inc.
Nuvectis Pharma, Inc.
Dutch Society of Physicians for Pulmonology and Tuberculosis
A2 Biotherapeutics Inc.
Zhejiang University
National Institutes of Health Clinical Center (CC)
University of Chicago
A2 Biotherapeutics Inc.
University Hospital, Lille
Royal Marsden NHS Foundation Trust
University of Nebraska
PrECOG, LLC.
Takeda
Lumicell, Inc.
Perspective Therapeutics
Seagen Inc.
Dana-Farber Cancer Institute
Novartis
Stanford University
Fundación GECP
National Institutes of Health Clinical Center (CC)
Kezar Life Sciences, Inc.
H. Lee Moffitt Cancer Center and Research Institute
VM Oncology, LLC
Dana-Farber Cancer Institute
Bristol-Myers Squibb